Preferred Label : Epclusa;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3337733/fr/epclusa-sofosbuvir/-velpatasvir-vhc
2022
false
false
false
France
evaluation of the transparency committee
velpatasvir
hepacivirus
Epclusa
velpatasvir

---
https://www.has-sante.fr/jcms/p_3299655/fr/epclusa-sofosbuvir/-velpatasvir
2021
false
false
false
France
evaluation of the transparency committee
velpatasvir
velpatasvir
Epclusa
registries
outcome studies
Outcome Assessment, Health Care
resulting in

---
https://www.has-sante.fr/jcms/p_3152667/fr/epclusa
2020
false
false
false
France
Sofosbuvir
velpatasvir
sofosbuvir-velpatasvir drug combination
sofosbuvir and velpatasvir
hepatitis C, chronic
evaluation of the transparency committee
Epclusa
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.